Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cartesian Therapeutics (RNAC) Tax Rate (2021 - 2022)

Historic Tax Rate for Cartesian Therapeutics (RNAC) over the last 2 years, with Q4 2022 value amounting to 5.14%.

  • Cartesian Therapeutics' Tax Rate fell 62500.0% to 5.14% in Q4 2022 from the same period last year, while for Dec 2022 it was 73.75%, marking a year-over-year decrease of 6496800.0%. This contributed to the annual value of 0.37% for FY2024, which is 83300.0% down from last year.
  • Cartesian Therapeutics' Tax Rate amounted to 5.14% in Q4 2022, which was down 62500.0% from 3.91% recorded in Q3 2022.
  • In the past 5 years, Cartesian Therapeutics' Tax Rate ranged from a high of 3.91% in Q3 2022 and a low of 766.12% during Q3 2021